- Home
- MSGS vs BIRK Comparison
MSGS vs BIRK Comparison
Compare MSGS & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MSGS | BIRK |
|---|---|---|
| Founded | 1879 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 7.0B |
| IPO Year | 2015 | 2023 |
Fundamental Metrics
Financial Performance| Metric | MSGS | BIRK |
|---|---|---|
| Price | $346.81 | $38.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 14 |
| Target Price | ★ $341.29 | $61.43 |
| AVG Volume (30 Days) | 200.4K | ★ 1.9M |
| Earning Date | 05-04-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $13.71 |
| Revenue Next Year | $4.52 | $14.30 |
| P/E Ratio | ★ N/A | $17.48 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $186.00 | $33.06 |
| 52 Week High | $345.50 | $57.39 |
Technical Indicators
Market Signals| Indicator | MSGS | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 60.45 | 51.27 |
| Support Level | $320.74 | $37.73 |
| Resistance Level | N/A | $42.31 |
| Average True Range (ATR) | 10.95 | 1.51 |
| MACD | -0.68 | -0.06 |
| Stochastic Oscillator | 83.59 | 37.86 |
Price Performance
Historical ComparisonAbout MSGS Madison Square Garden Sports Corp. (New)
Madison Square Garden Sports Corp owns and operates a portfolio of assets featuring some of the recognized sports teams, including the Knicks of the NBA and the Rangers of the NHL. It generates revenue from several sources: ticket sales and a portion of suite rental fees at The Garden and others. It has one operating and reportable segment and one reporting unit for goodwill impairment testing purposes.
About BIRK Birkenstock Holding plc
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.